文献速递骨质疏松与钙磷/甲状旁腺性腺与生殖内分泌

内源性硫酸脱氢表雄酮与女性腰椎骨密度及前臂骨折存在因果关联

Endogenous DHEAS Is Causally Linked With Lumbar Spine Bone Mineral Density and Forearm Fractures in Women.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

采用两样本孟德尔随机化方法,以女性特异性全基因组关联研究荟萃分析(n=8565)的血清硫酸脱氢表雄酮(DHEAS)遗传预测因子,评估其与腰椎骨密度(n=22900)及英国生物银行238565名白人女性骨折(前臂骨折11564例、髋部骨折2604例)的因果关联。结果显示,遗传预测的DHEAS每升高1个标准差,腰椎骨密度增加0.21个标准差(P=0.01),估算跟骨骨密度增加0.08个标准差(P<0.001),前臂骨折风险降低(OR 0.70,95%CI 0.55-0.88),与髋部骨折无显著因果关联。

要点

  • 遗传预测的血清DHEAS每升高1个标准差,腰椎骨密度增加0.21个标准差(P=0.01)。
  • 遗传预测的DHEAS每升高1个标准差,前臂骨折风险降低(OR 0.70,95%CI 0.55-0.88)。
  • 遗传预测的DHEAS与髋部骨折无显著因果关联。

核心结论

  • 遗传预测的血清DHEAS可增加女性腰椎骨密度并降低前臂骨折风险。
  • 基于本研究结果及既往DHEA治疗随机对照试验,作者提出内源性肾上腺来源的DHEA(S)与药物性DHEA治疗均改善女性骨骼健康。

研究设计与样本

  • 两样本孟德尔随机化研究,血清DHEAS遗传预测因子来自目前最大的女性特异性全基因组关联研究荟萃分析(n=8565)。
  • 骨密度遗传关联来自骨质疏松遗传因素联盟的女性特异性全基因组关联研究汇总统计(n=22900,双能X线吸收法测得骨密度)。
  • 骨折关联及超声估算跟骨骨密度(eBMD)分析使用英国生物银行238565名白人女性的个体水平数据(前臂骨折11564例,髋部骨折2604例)。

主要发现

  • 遗传工具变量预测的血清DHEAS对数水平每升高1个标准差,腰椎骨密度增加0.21个标准差(P=0.01)。
  • 遗传工具变量预测的血清DHEAS对数水平每升高1个标准差,估算跟骨骨密度增加0.08个标准差(P<0.001)。
  • 遗传预测的DHEAS每升高1个标准差,前臂骨折风险降低(OR 0.70,95%CI 0.55-0.88)。
  • 遗传预测的DHEAS与髋部骨折无显著因果关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: A recent pooled analysis of four clinical trials demonstrated that treatment with dehydroepiandrosterone (DHEA) increases lumbar spine bone mineral density (LS-BMD) in women. The causal effect of endogenous adrenal-derived DHEA sulphate (DHEAS) on LS-BMD and fracture risk in women is unknown. OBJECTIVE: To determine whether circulating DHEAS is causally associated with LS-BMD and fracture risk in women. METHODS: A 2-sample Mendelian randomization study using genetic predictors of serum DHEAS derived from the largest available female-specific genome wide association study (GWAS) meta-analysis (n = 8565). Genetic associations with dual-energy X-ray absorptiometry-derived BMD (n = 22 900) were obtained from female-specific GWAS summary statistics available from the Genetic Factors for Osteoporosis consortium while individual-level data of 238 565 women of white ancestry from the UK Biobank were used for associations with fractures (11 564 forearm fractures, 2604 hip fractures) and estimated heel BMD by ultrasound (eBMD). RESULTS: A 1 SD genetically instrumented increase in log serum DHEAS levels was associated with a 0.21 SD increase in LS-BMD (P = 0.01) and a 0.08 SD increase in eBMD (P < 0.001). Genetically predicted DHEAS decreased forearm fracture risk (odds ratio 0.70, 95% CI 0.55-0.88 per SD increase in DHEAS) while no significant causal association with hip fractures was observed. CONCLUSIONS: Genetically predicted serum DHEAS increases LS-BMD and decreases forearm fracture risk in women. Based on the results of the present study and previous randomized controlled trials of DHEA treatment, we propose that both endogenous adrenal-derived DHEA(S) and pharmacological DHEA treatment improve bone health in women.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Quester J, Nethander M, Eriksson A, et al. Endogenous DHEAS Is Causally Linked With Lumbar Spine Bone Mineral Density and Forearm Fractures in Women. J Clin Endocrinol Metab. 2022. PMID: 34935937. doi:10.1210/clinem/dgab915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。